title: Heart failure in 2013: Continue what we are doing to treat HF, but do it better.
abstract: In 2013, clinical trials in heart failure focused on drugs and devices that might improve treatment of symptomatic patients beyond standard therapy. None achieved this aim. Therefore, future efforts should emphasize increased adherence to current, evidence-based therapy, and trials might better address efforts to prevent, rather than treat, heart failure.
authors.affiliation: Cardiovascular Division, University of Minnesota Medical School, Mayo Mail Code 508, 420 Delaware Street Southeast, Minneapolis, MN 55455, USA.
authors.forename: Jay N
authors.initials: JN
authors.lastname: Cohn
mesh_terms: D058406:Cardiac Resynchronization Therapy / Q000379:methods*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D019317:Evidence-Based Medicine / Q000379:methods*; D014943:Global Health; D006333:Heart Failure / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D015995:Prevalence; D011379:Prognosis; D012189:Retrospective Studies